Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
Retinoid X receptor agonist
DRUG CLASS:
Retinoid X receptor agonist
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
IRX4204 (4)
MSU-42011 (0)
alitretinoin topical (0)
bexarotene topical (0)
UAB30 (0)
K-333 (0)
IRX4204 (4)
MSU-42011 (0)
alitretinoin topical (0)
bexarotene topical (0)
UAB30 (0)
K-333 (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
HER-2 overexpression
Breast Cancer
HER-2 overexpression
Breast Cancer
neratinib + IRX4204
Sensitive: D – Preclinical
neratinib + IRX4204
Sensitive
:
D
neratinib + IRX4204
Sensitive: D – Preclinical
neratinib + IRX4204
Sensitive
:
D
HER-2 overexpression
Breast Cancer
HER-2 overexpression
Breast Cancer
tucatinib + IRX4204
Sensitive: D – Preclinical
tucatinib + IRX4204
Sensitive
:
D
tucatinib + IRX4204
Sensitive: D – Preclinical
tucatinib + IRX4204
Sensitive
:
D
HER-2 overexpression
Breast Cancer
HER-2 overexpression
Breast Cancer
trastuzumab + IRX4204
Sensitive: D – Preclinical
trastuzumab + IRX4204
Sensitive
:
D
trastuzumab + IRX4204
Sensitive: D – Preclinical
trastuzumab + IRX4204
Sensitive
:
D
HER-2 overexpression
Breast Cancer
HER-2 overexpression
Breast Cancer
IRX4204
Sensitive: D – Preclinical
IRX4204
Sensitive
:
D
IRX4204
Sensitive: D – Preclinical
IRX4204
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login